Dr. Li is a Fellow in Gynecologic Oncology
What’s new in biomarker testing for ovarian cancer
Three tests are now FDA-approved for triaging pelvic masses in asymptomatic women.
Letters to the Editor
Letters discuss the myriad of issues affecting the practice of specialties. Joshua A. Copel responds.
Letters discuss global endometrial ablations, intrauterine scarring, and disagreements over cancer biomarkers. Steven R. Goldstein and Andrew John Li respond.
2 Commerce Drive Cranbury, NJ 08512